Home › Funds › HARTLINE INVESTMENT CORP/ › GEHC

HARTLINE INVESTMENT CORP/ position in GEHC

GE HEALTHCARE TECHNOLOGIES I · Health Care

HARTLINE INVESTMENT CORP/ reported holding 97,526 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$6.4M, representing 0.66% of its reported portfolio and ranking #30 among its reported holdings. HARTLINE INVESTMENT CORP/ has disclosed GEHC holdings in 6 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)97.53K sh
Reported value held$6.38M
Portfolio Weight0.66%
First reportedQ1 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HARTLINE INVESTMENT CORP/'s GEHC position evolved

HARTLINE INVESTMENT CORP/ first disclosed a stake in GEHC in Q1 2024 at 6,695 shares (US$609K). The position peaked in Q3 2026 at 97,526 shares, worth US$6.4M. Across 6 filings, HARTLINE INVESTMENT CORP/ increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 97,526 shares valued at US$6.4M — an increase of 4,779 shares quarter over quarter.. Notable position changes include a 250% increase in Q4 2025 (shares fell 14% over the following quarter), a 718% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 6.70K $608.64K New
Q3 2025 2.67K $200.52K New
Q4 2025 9.34K $766.23K Add
Q1 2026 11.33K $806.75K Add
Q2 2026 92.75K $5.94M Add
Q3 2026 97.53K $6.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GEHC and 13F data

GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GEHC

All GEHC fund holders →

FAQ

How long has HARTLINE INVESTMENT CORP/ held GEHC?

HARTLINE INVESTMENT CORP/ has disclosed GEHC holdings in 6 of the last 11 reported quarters, going back to Q1 2024.

What is HARTLINE INVESTMENT CORP/'s current position in GEHC?

As of Q3 2026, HARTLINE INVESTMENT CORP/ holds 97.53K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $6.38M, representing 0.66% of its reported portfolio and ranking #30.

Has HARTLINE INVESTMENT CORP/ been buying or selling GEHC?

In the latest 13F filing (Q3 2026), HARTLINE INVESTMENT CORP/ increased its position in GEHC. The position peaked in Q3 2026 at 97.53K shares.

Which other funds hold GEHC?

Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.